12 Abu Dhabi healthtech investors fund digital health in 2026. M42, PureHealth, and Mubadala lead the biggest deals. Abu Dhabi's life-sciences cluster targets AED 94B in GDP by 2045.
Abu Dhabi is building a global health and life-sciences hub. M42 and PureHealth anchor it with deep sovereign money.
ADQ and Mubadala fund pharma and care platforms at scale. Hub71 and Plug and Play seed the earliest founders.
Most health deals here need clinical proof and a clear regulatory path. Ellty tracks every data room open from M42, PureHealth, and ADQ reviewers.
This guide covers 12 active Abu Dhabi healthtech investors in 2026.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| M42 | Health-AI company / investor | Strategic | Health AI, genomics, diagnostics | m42.ae |
| PureHealth | Healthcare group / acquirer | $100M-$1B+ | Hospitals, diagnostics, insurance | purehealth.ae |
| Mubadala Bio | Sovereign life-sciences fund | Strategic | Biopharma, drug security, life sciences | mubadalabio.ae |
| ADQ | Sovereign health holding | Strategic | Pharma, healthcare, life sciences | adq.ae |
| Hub71 | Accelerator | AED 250K+ SAFE | Healthtech, biotech, medtech | hub71.com |
| Plug and Play Abu Dhabi | Accelerator / CVC | Seed / strategic | Digital health, medtech | plugandplaytechcenter.com |
| Burjeel Holdings | Healthcare group / investor | Strategic | Hospitals, clinical AI, EMR | burjeelholdings.com |
| Arcera Life Sciences | Pharma / life-sciences platform | Strategic | Pharma, biotech, life sciences | arceralifesciences.com |
| Shorooq Partners | Seed / Series A VC | $1M-$10M | Healthtech, medtech, life sciences | shorooq.com |
| Global Ventures | Seed / Series A-B VC | $1M-$15M | Healthtech, digital health, deep tech | global.vc |
| VentureSouq | Seed VC fund manager | $250K-$3M | Healthtech, fintech, foodtech | venturesouq.com |
| e& capital | Corporate VC | $5M-$20M | Healthtech, fintech, enterprise tech | eand.com |
Control your Abu Dhabi health raise
Health funds open your clinical docs and data room before your deck. Ellty logs every view.
Start free 14-day trialWhat a health investor backs
A health investor backs digital health, biotech, medtech, or care delivery. In Abu Dhabi that means strict patient-data rules.
Sovereign players like M42 fund AI diagnostics and genomics at scale. Smaller VCs back the earliest digital-health founders.
They want clinical evidence, a regulatory plan, and data security. Founders pitching healthtech VCs in Dublin face the same bar.
Ellty gives each fund one trackable link and logs every open. You see who reviewed your clinical data before the call.
With Hub71+ Life Sciences, we are channeling our experience into a dedicated environment where founders, researchers, and investors can advance healthcare innovation.
12 Abu Dhabi healthtech investors
1. M42
M42 is Abu Dhabi's health-AI champion, built by Mubadala and G42.
Recent Activity: Forged tie-ups with Oracle Health, GE HealthCare, and AstraZeneca to scale AI diagnostics from Abu Dhabi
LinkedIn: M42 LinkedIn
Sector Focus: Health AI, genomics, precision medicine, diagnostics
Stage Focus: Strategic, growth
Location: Abu Dhabi, UAE
Website: m42.ae
2. PureHealth
PureHealth is Abu Dhabi's largest healthcare group and a major strategic acquirer.
Recent Activity: Acquired 60% of Greece's Hellenic Healthcare Group for around $933M in Oct 2025
LinkedIn: PureHealth LinkedIn
Sector Focus: Hospitals, diagnostics, health insurance, data
Stage Focus: Strategic, M&A
Location: Abu Dhabi, UAE
Website: purehealth.ae
3. Mubadala Bio
Mubadala Bio is the sovereign fund's life-sciences national champion.
Recent Activity: Launched May 2025 with 10 facilities, parent Mubadala joined WHOOP's $575M round
LinkedIn: Mubadala LinkedIn
Sector Focus: Biopharma, drug security, pharma logistics
Stage Focus: Strategic, growth
Location: Abu Dhabi, UAE
Website: mubadalabio.ae
4. ADQ
ADQ is an Abu Dhabi sovereign investor and the anchor behind PureHealth and Arcera.
Recent Activity: Acquired Pharmax and took a minority stake in Biocon Biologics in 2025
LinkedIn: ADQ LinkedIn
Sector Focus: Pharma, healthcare delivery, life sciences
Stage Focus: Strategic, M&A
Location: Abu Dhabi, UAE
Website: adq.ae
5. Hub71
Hub71 runs a dedicated Life Sciences track for Abu Dhabi health founders.
Recent Activity: Launched Hub71+ Life Sciences in late 2025 with the Department of Health and the HELM cluster
LinkedIn: Hub71 LinkedIn
Sector Focus: Healthtech, biotech, medtech, digital health
Stage Focus: Pre-seed, seed
Location: Abu Dhabi, UAE
Website: hub71.com
6. Plug and Play Abu Dhabi
Plug and Play runs MENA's first health accelerator with Abu Dhabi's health regulator.
Recent Activity: Runs 2025 cohorts connecting startups to Cleveland Clinic, J&J, AstraZeneca, and Roche
LinkedIn: Plug and Play Abu Dhabi LinkedIn
Sector Focus: Digital health, medtech, healthcare innovation
Stage Focus: Seed, early
Location: Abu Dhabi, UAE
Website: plugandplaytechcenter.com
Share clinical docs and track every fund open
Ellty shows when M42 or PureHealth opens your trial data and deck. Follow up fast.
Start free 14-day trial7. Burjeel Holdings
Burjeel Holdings is a listed Abu Dhabi hospital group investing in clinical AI.
Recent Activity: Deployed a major Oracle Health EMR Feb 2025, unveiled an AI diagnostics suite, profit up 39.5%
LinkedIn: Burjeel Holdings LinkedIn
Sector Focus: Hospitals, clinical AI, EMR, digital health
Stage Focus: Strategic, growth
Location: Abu Dhabi, UAE
Website: burjeelholdings.com
8. Arcera Life Sciences
Arcera Life Sciences is ADQ's pharma and life-sciences platform in Abu Dhabi.
Recent Activity: ADQ's dedicated life-sciences arm building pharma manufacturing and supply across the UAE
LinkedIn: Arcera Life Sciences LinkedIn
Sector Focus: Pharma, biotech, life sciences
Stage Focus: Strategic, growth
Location: Abu Dhabi, UAE
Website: arceralifesciences.com
9. Shorooq Partners
Shorooq Partners backs healthtech and medtech founders from its ADGM base.
Recent Activity: Around $500M AUM, made 9 investments in 2025, runs a $100M AI fund with Presight
LinkedIn: Shorooq Partners LinkedIn
Sector Focus: Healthtech, medtech, life sciences, fintech
Stage Focus: Pre-seed to Series A
Location: Abu Dhabi, UAE
Website: shorooq.com
10. Global Ventures
Global Ventures is an active MENA healthtech backer of digital-health founders.
Recent Activity: Portfolio includes Helium Health and Klaim, with steady digital-health deal flow in 2025
LinkedIn: Global Ventures LinkedIn
Sector Focus: Healthtech, digital health, deep tech
Stage Focus: Seed to Series B
Location: Abu Dhabi / Dubai, UAE
Website: global.vc
11. VentureSouq
VentureSouq is an ADGM fund manager backing early healthtech among other sectors.
Recent Activity: ADGM-regulated fund manager investing across healthtech and 40+ early-stage MENA startups
LinkedIn: VentureSouq LinkedIn
Sector Focus: Healthtech, fintech, climatetech, foodtech
Stage Focus: Pre-seed, seed
Location: Abu Dhabi, UAE
Website: venturesouq.com
12. e& capital
e& capital is the telecom group's VC arm, backing healthtech and enterprise tech.
Recent Activity: Around 16 portfolio companies, co-led Fuze's $12.2M Series A, invests across healthtech
LinkedIn: e& capital LinkedIn
Sector Focus: Healthtech, fintech, enterprise tech
Stage Focus: Series A, Series B
Location: Abu Dhabi, UAE
Website: eand.com
M42 and the health-AI push
M42 sits at the center of Abu Dhabi's health-AI bet. It pairs genomics, AI, and care across many countries.
Partners like Oracle and AstraZeneca scale its diagnostics globally. PureHealth and Burjeel run the hospitals behind it.
Health AI lives or dies on clean model and data provenance. Gate your docs with granular permissions in Ellty.
Run a full AI due diligence review before you raise. Health funds probe data sourcing and bias very hard.
Building a life-sciences cluster
Abu Dhabi is building HELM, a dedicated life-sciences cluster. It targets AED 94B in GDP and 30,000 jobs by 2045.
DoH, the Emirates Drug Establishment, and Hub71 anchor the plan. Founders get regulators and capital in one place here.
Joining the cluster means clean trial data and approvals ready. Built-in document analytics show you exactly who studied them.
Run a full cybersecurity due diligence review first. UAE health funds probe your data handling very hard.
Data, trials, and approvals
Abu Dhabi health deals hinge on patient data, trials, and approval. Investors check all three before they commit capital.
Strong evidence and a clean consent flow beat a slick demo. Weak data governance ends most health pitches early.
Protect clinical decks with password protection on every link. Ellty shows you exactly who opened each clinical file.
Send monthly trial and traction updates to keep funds engaged. A clean pitch deck tracking flow shows interest.
How to pitch an Abu Dhabi health investor
Lead with clinical proof, data rights, and approvals.
- 1.Bring clinical evidence, not just a demo.Health funds back proof, not promising apps.
- 2.Show a clear DoH regulatory pathway.A licence plan unlocks UAE health funding.
- 3.Prove patient-data security and consent.Weak data controls sink most health pitches.
- 4.Share one Ellty link per fund and track opens.Follow up when a fund reads your trial data.
How Ellty helps you land a health investor in Abu Dhabi
You've found your Abu Dhabi health funds already. Set up a data room before your first pitch.
- 1.Upload your deck, trial data, and approvals to Ellty.Set NDA-gated access per health investor.
- 2.Share a unique trackable link with each fund.Each fund gets one link. Ellty logs every open.
- 3.Track opens and follow up the moment they read.Use Ellty analytics to time your follow-up.
Abu Dhabi healthtech investor questions
- Sovereign funds, hospitals, and accelerators do. M42, PureHealth, and Hub71 lead.
- From seed cheques to billion-dollar deals. Sovereign players write the largest.
- Clinical proof, a regulatory path, and data security. Apps without evidence rarely fund.
- Abu Dhabi's health-AI company by Mubadala and G42. It scales genomics and AI diagnostics.
- Yes, founders raise here from abroad. A UAE entity opens most health networks.
- Before outreach starts. Track who opens your clinical and trial docs.
